Fatty acids and breast cancer: the role of stem cells.

Department of Cell Biology and Human Anatomy, University of California, School of Medicine, Davis, CA 95616-8643, USA.
Prostaglandins Leukotrienes and Essential Fatty Acids (Impact Factor: 1.98). 04/2010; 82(4-6):237-41. DOI: 10.1016/j.plefa.2010.02.019
Source: PubMed

ABSTRACT Studies with animal models in vivo as well as with animal and human tumor cells in vitro suggest that specific fatty acids could reduce breast tumorigenesis. The most striking dietary fatty acid studies in animal models that show promise for reduction of breast cancer risk in humans are with conjugated linoleic acids (CLA) and n-3 fatty acids. Although a number of mechanisms have been proposed, the specific target of those fatty acids is not yet known. We sought to determine whether the effects of those fatty acids on terminally differentiated tumor cell seen could be due to alteration of breast cancer stem cells. The isomers, cis9, trans11-CLA and trans10, cis12-CLA, and the n-3 fatty acids, docosahexaenoic and eicosapentaenoic, reduced the proliferation of, and had increased toxicity towards, mammary tumor initiating cells. One mechanism involved in the effect of n-3 fatty acids may be due to alteration of the profile of prostaglandins. These results indicate that select fatty acids may be useful for preventing or reducing the risk of breast cancer as they may target the tumor initiating cell.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological and experimental studies have convincingly demonstrated that n-3 polyunsaturated fatty acids (PUFAs) inhibit the initiation and progression stages of colorectal cancer. Attenuation of cell proliferation and induction of apoptosis by modulation of multiple signaling pathways makes n-3 PUFAs a promising candidate for chemoprevention as well as a dietary adjuvant with other anticancer strategies. These PUFAs maintain intestinal homeostasis by regulating stem cell proliferation mediated through downregulation of Wnt signaling and upregulation of transforming growth factor β mediated signaling events. In addition, owing to their anti-inflammatory nature, these fatty acids also affect the intestinal milieu which has a critical role in maintaining the number of stem cells and their differentiation.
    Current Colorectal Cancer Reports 12/2012; 8(4). DOI:10.1007/s11888-012-0145-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: The quantity and makeup of dietary fat intake are known to impact human health. Use of Omega-3 (ω-3) polyunsaturated fatty acid (PUFA) supplements has gained increasing attention for a variety of purported health benefits, including cancer prevention. Preclinical evidence has been encouraging and recent studies have expanded our understanding of the mechanisms by which ω-3 PUFAs may protect against breast cancer. However, epidemiologic studies have yielded mixed results. Recent population studies have attempted to delineate factors that may influence the effects of ω-3 PUFAs such as total fat intake and the ratio of ω-3 to ω-6 PUFA intake. Several clinical trials, including some currently ongoing, are investigating novel strategies that favorably alter endogenous fatty acid profiles in an effort to develop clinically feasible prevention methods. Identification of well-defined subpopulations that are most likely to benefit from a targeted prevention approach will likely be crucial in this effort.
    Current Breast Cancer Reports 09/2013; 5(3):247-254. DOI:10.1007/s12609-013-0112-1
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Globally, the prevalence of obesity is increasing which subsequently increases the risk of the development of obesity-related chronic diseases. Low-grade chronic inflammation and dysregulated adipose tissue inflammatory mediator/adipokine secretion are well-established in obesity, and these factors increase the risk of developing inflammation-associated cancer. Breast cancer is of particular interest given that increased inflammation within the subcutaneous mammary adipose tissue depot can alter the local tissue inflammatory microenvironment such that it resembles that of obese visceral adipose tissue. Therefore, in obese women with breast cancer, increased inflammatory mediators both locally and systemically can perpetuate inflammation-associated pro-carcinogenic signaling pathways, thereby increasing disease severity. Herein, we discuss some of these inflammation-associated pro-carcinogenic mechanisms of the combined obese breast cancer phenotype and offer evidence that dietary long chain n-3 polyunsaturated fatty acids (PUFA) may have utility in mitigating the severity of obesity-associated inflammation and breast cancer.
    Nutrients 11/2014; 6(11):4760-4793. DOI:10.3390/nu6114760 · 3.15 Impact Factor